logo
Share SHARE
FONT-SIZE Plus   Neg

Total Still Investigating Cause Of North Sea Gas Leak

French oil giant Total SA (TOT, TTFNF.PK, TTA.L) Monday said it is progressing with its actions to stop the gas leak incident on the plugged G4 production well on Elgin platform in North Sea. The company is still investigating the cause of the gas leak, but estimates the gas leakage rate to be nearly 7 Mcf/d.

Last Tuesday, Total confirmed the gas leak which started that weekend. The company said its actions to stop the leakage include pumping of heavy mud directly into the well and drilling of relief wells to intervene at the source of the gas flow.

Total noted that the size of the flare diminishing and the current impact and risks for the environment are relatively low.

According to Total, it will deploy Sedco 714 and Rowan Gorilla V, the two available drilling rigs under contract in the area, for the drilling of the relief wells.

The UK authorities have already set up an exclusion zone around the platform as a wide safety margin. The company also stated that cooperation and coordination with relevant UK authorities is ongoing.

The gas leak has also forced Royal Dutch Shell Plc. (RDS-A, RDSA.L, RDSB.L, RDS-B) to shut down and evacuate workers from Shearwater and Noble Hans Deul rigs, after a safety exclusion zone of two miles was declared by the authorities.

Total said it will continue to make regular updates on the situation.

In Paris, Total shares are currently trading at 38.68 euros, up 1.13 percent, on a volume of 731 thousand shares. In the US, the shares ended on Friday at $51.12.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The European Union's executive arm has ordered the Irish government to recover up to 13 billion euros, or $14.5 billion, in taxes from Apple Inc. The European Commission said it has concluded that Ireland granted the U.S. tech giant undue tax benefits of up to 13 billion euros, which is illegal under EU state aid rules. Shares of Apple are down 1 percent in pre-market activity. Abercrombie & Fitch Co. (ANF) reported Tuesday a wider year-over-year net loss for the second-quarter, hurt by a impairment charge. Net sales for the quarter were down 4%, with comparable sales declined 4%. Quarterly loss was wider than their expectations, but revenues beat their' estimates. The performance of Biotech stocks thus far this month is nothing to write home about, if we were to look at it from the standpoint of the movement of the NYSE Arca Biotechnology Index. A peek at what transpired on the FDA front in August and a preview of what September holds in store for us look pertinent.
comments powered by Disqus
Follow RTT